New drug budoprutug aims to boost platelets in ITP patients
NCT ID NCT07043946
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tests a new drug called budoprutug in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants must have very low platelet counts despite prior treatments. The main goal is to check safety, but researchers will also measure how the drug works in the body and if it improves platelet levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOCLONAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Climb Bio Investigative Site #300201
RECRUITINGThessaloniki, 57010, Greece
-
Climb Bio Investigative Site #300202
RECRUITINGIoannina, 45500, Greece
-
Climb Bio Investigative Site #300203
RECRUITINGChaïdári, Attica, 12462, Greece
-
Climb Bio Investigative Site #300204
RECRUITINGAthens, Attica, 11527, Greece
-
Climb Bio Investigative Site #340202
RECRUITINGSan Pedro, Spain
-
Climb Bio Investigative Site #340203
RECRUITINGValencia, 46010, Spain
-
Climb Bio Investigative Site #340204
RECRUITINGMadrid, 28041, Spain
-
Climb Bio Investigative Site #340206
NOT_YET_RECRUITINGBurgos, 9006, Spain
-
Climb Bio Investigative Site #359201
RECRUITINGSofia, 1797, Bulgaria
-
Climb Bio Investigative Site #359202
RECRUITINGPlovdiv, 4002, Bulgaria
-
Climb Bio Investigative Site #359203
RECRUITINGPlovdiv, 4003, Bulgaria
-
Climb Bio Investigative Site #380208
NOT_YET_RECRUITINGCherkasy, Ukraine
-
Climb Bio Investigative Site #381201
RECRUITINGBelgrade, Serbia
-
Climb Bio Investigative Site #381202
RECRUITINGBelgrade, Serbia
-
Climb Bio Investigative Site #381203
RECRUITINGNovi Sad, Serbia
-
Climb Investigative Site #2380203
RECRUITINGKyiv, Ukraine
-
Climb Investigative Site #380201
RECRUITINGLviv, Ukraine
-
Climb Investigative Site #380202
RECRUITINGKyiv, Ukraine
-
Climb Investigative Site #380204
RECRUITINGIvano-Frankivsk, Ukraine
-
Climb Investigative Site #380206
RECRUITINGKyiv, Ukraine
Conditions
Explore the condition pages connected to this study.